These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32657553)

  • 1. Cardiac contractility modulation in left ventricular systolic dysfunction: one-year experience in a pilot study and design of a prospective registry.
    Matta M; Devecchi C; DE Vecchi F; Barbonaglia L; Gravellone M; Occhetta E; Rametta F
    Minerva Cardiol Angiol; 2021 Feb; 69(1):15-24. PubMed ID: 32657553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Year Outcome of Cardiac Contractility Modulation in Patients With Reduced Ejection Fraction, Atrial Fibrillation, and Previous Resynchronization: A Pilot Study.
    Tint D; Micu S
    Am J Ther; 2023 Jan-Feb 01; 30(1):e10-e16. PubMed ID: 36367992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of baseline left ventricular ejection fraction on long-term outcomes in cardiac contractility modulation therapy.
    Yücel G; Fastner C; Hetjens S; Toepel M; Schmiel G; Yazdani B; Husain-Syed F; Liebe V; Rudic B; Akin I; Borggrefe M; Kuschyk J
    Pacing Clin Electrophysiol; 2022 May; 45(5):639-648. PubMed ID: 35262210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system.
    Kuschyk J; Falk P; Demming T; Marx O; Morley D; Rao I; Burkhoff D
    Eur J Heart Fail; 2021 Jul; 23(7):1160-1169. PubMed ID: 34002440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation: results of the 12-month follow-up].
    Safiullina AA; Uskach TM; Sapelnikov OV; Grishin IR; Cherkashin DI; Amanatova VA; Akchurin RS; Tereshchenko SN
    Ter Arkh; 2022 Oct; 94(9):1078-1084. PubMed ID: 36286759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads.
    Röger S; Said S; Kloppe A; Lawo T; Emig U; Rousso B; Gutterman D; Borggrefe M; Kuschyk J
    J Cardiol; 2017 Jan; 69(1):326-332. PubMed ID: 27590412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study.
    Fastner C; Yuecel G; Hetjens S; Rudic B; Schmiel G; Toepel M; Liebe V; Kruska M; Borggrefe M; Burkhoff D; Akin I; Duerschmied D; Kuschyk J
    Clin Res Cardiol; 2022 Nov; 111(11):1286-1294. PubMed ID: 36056955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study.
    Conceição-Souza GE; Pêgo-Fernandes PM; Cruz Fd; Guimarães GV; Bacal F; Vieira ML; Grupi CJ; Giorgi MC; Consolim-Colombo FM; Negrão CE; Rondon MU; Moreira LF; Bocchi EA
    Eur J Heart Fail; 2012 Dec; 14(12):1366-73. PubMed ID: 23099357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportion of Patients Eligible for Cardiac Contractility Modulation: Real-Life Data from a Single-Center Heart Failure Clinic.
    Pilecky D; Muk B; Majoros Z; Vágány D; Kósa K; Szabó M; Szögi E; Dékány M; Kiss RG; Nyolczas N
    Cardiology; 2021; 146(2):195-200. PubMed ID: 33582674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120-149 ms: Reduction in heart failure hospitalizations and improvement in functional outcome.
    Fastner C; Varma N; Rao I; Falk P; Remppis BA; Najarian K; Burkhoff D; Akin I; Kuschyk J
    Heart Rhythm; 2024 Sep; ():. PubMed ID: 39306264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF).
    Linde C; Grabowski M; Ponikowski P; Rao I; Stagg A; Tschöpe C
    Eur J Heart Fail; 2022 Dec; 24(12):2275-2284. PubMed ID: 35855646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function.
    Tschöpe C; Butler J; Farmakis D; Morley D; Rao I; Filippatos G
    ESC Heart Fail; 2020 Dec; 7(6):3531-3535. PubMed ID: 33274601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.